Skip to main content
OpenTrials
Completed

NCT Number: NCT01056640

Telemonitoring Versus Usual Care

Background: Older adults with multiple chronic illnesses are at risk for worsening functional and medical status with ensuing hospitalization. One goal of medical care is to prevent this decline. One method that may help slow this functional and medical decline is home telemonitoring.

Specific aim: To determine the effectiveness of home telemonitoring compared to usual care in reducing combined outcomes of hospitalization and emergency room visits in an at risk population over 60 years of age.

Materials and Methods: This will be a randomized trial of 200 patients into one of two interventions. Home telemonitoring involves the use of a computer device at home which records biometric and symptom data from patients. This information is monitored by mid level providers associated with the primary care medical practice. Usual care involves patients who make appointments with their providers as problems arise and utilize ongoing support like a 24 hours nurse line. The study participants are adults over 60 years of age within the highest 10% on elderly risk assessment (ERA) scores. Patients will have initial evaluations of gait, quality of life (SF12), Kokmen test of mental status, and PHQ 9. Patients will be followed for 1 year for primary outcomes of hospitalizations and emergency room visits. Secondary analysis will include quality of life, compliance with the device and attitudes about telemonitoring. Sample size is based upon an 80% power to detect a 36% difference between the groups. The primary analysis will involve Cox proportional time to event analysis comparing both interventions for telemonitoring or usual care. Secondary analysis will use T-test comparisons for continuous variables (quality of life, attitudes) and chi square for proportional analysis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion:

  • at least 60 years of age;
  • have an Elder Risk Assessment (ERA) Index score of 16 or greater;
  • Are able to participate fully in all aspects of the study;
  • Have been provided with, understand, and have signed the informed consent;

Exclusion:

  • patients who are currently residing in a nursing home
  • patients with a clinical diagnosis of dementia
  • patients with a score of ≤29 on the Kokmen short test of mental status
  • patients for whom we cannot obtain informed consent.
  • patient under the age of 60 will also be excluded from participating.
  • patients who have not granted Universal Research Authorization to use medical records.
  • patients will also be excluded if the subject would not be able to use the interventional machine

Treatment and study plan

Intel Health Guide

Device

The Intel Health Guide is an FDA approved device that is placed within the patient's home and is connected to the health system via broadband internet, 3G network or phone line.

Usual Care

Other

The usual care intervention will include appropriate primary care and specialty office practice visits as required.

Primary outcomes

  1. Mean # Participants Who Had Hospitalizations or ED Visits Compared to Usual Care in a High Risk Group of Adults ≥ 60 Years of Age With Mixed Chronic Disease.

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • GE Healthcare

Registry information

Official study title

A Randomized Controlled Trial of Telemonitoring Versus Usual Care in a High Risk Elderly Population.

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Jan 26, 2010
Registry last updated
Feb 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.